Passive smoking is the inhalation of smoke, called second-hand smoke (SHS), or environmental tobacco smoke (ETS), by persons other than the intended "active" smoker. It occurs when tobacco smoke permeates any environment, causing its inhalation by people within that environment. Exposure to second-hand tobacco smoke causes disease, disability, and death. The health risks of second-hand smoke are a matter of scientific consensus. These risks have been a major motivation for smoke-free laws in workplaces and indoor public places, including restaurants, bars and night clubs as well as some open public spaces.
Concerns around second-hand smoke have played a central role in the debate over the harms and regulation of tobacco products. Since the early 1970s, the tobacco industry has viewed public concern over second-hand smoke as a serious threat to its business interests. Harm to bystanders was perceived as a motivator for stricter regulation of tobacco products. Despite the industry's awareness of the harms of second-hand smoke as early as the 1980s, the tobacco industry coordinated a scientific controversy with the aim of forestalling regulation of their products.:1242
General: overall increased risk; reviewing the evidence accumulated on a worldwide basis, the International Agency for Research on Cancer concluded in 2004 that "Involuntary smoking (exposure to secondhand or 'environmental' tobacco smoke) is carcinogenic to humans."
Lung cancer: passive smoking is a risk factor for lung cancer. In the United States passive smoke is estimated to cause more than 7,000 deaths from lung cancer a year among non-smokers.
Premature birth, part B, ch. 3 (Note that evidence of the causal link is only described as "suggestive" by the US Surgeon General in his 2006 report.) Laws limiting smoking decrease premature births.
Recent studies comparing women exposed to Environmental Tobacco Smoke and non-exposed women, demonstrate that women exposed while pregnant have higher risks of delivering a child with congenital abnormalities, longer lengths, smaller head circumferences, and low birth weight.
Worsening of asthma, allergies, and other conditions.
Childhood exposure to Environmental Tobacco Smoke is associated with an increased risk of the development of adult-onset Atopic dermatitis.
Overall increased risk of death in both adults, where it is estimated to kill 53,000 nonsmokers per year, making it the 3rd leading cause of preventable death in the U.S, and in children. The World Health Organization states that passive smoking causes about 600,000 deaths a year, and about 1% of the global burden of disease.
Risk to children
Sudden infant death syndrome (SIDS). In his 2006 report, the US Surgeon General concludes: "The evidence is sufficient to infer a causal relationship between exposure to secondhand smoke and sudden infant death syndrome." Secondhand smoking has been estimated to be associated with 430 SIDS deaths in the United States annually.
Lung infections, also including more severe illness with bronchiolitis and bronchitis, and worse outcome, as well as increased risk of developing tuberculosis if exposed to a carrier. In the United States, it is estimated that second hand smoke has been associated with between 150,000 and 300,000 lower respiratory tract infections in infants and children under 18 months of age, resulting in between 7,500 and 15,000 hospitalizations each year.
Impaired respiratory function and slowed lung growth
Exposure to secondhand smoke by age, race, and poverty level in the US.
Epidemiological studies show that non-smokers exposed to second-hand smoke are at risk for many of the health problems associated with direct smoking. Most of the research has come from studies of nonsmokers who are married to a smoker. Those conclusions are also backed up by further studies of workplace exposure to smoke.
In 1992, a review estimated that second-hand smoke exposure was responsible for 35,000 to 40,000 deaths per year in the United States in the early 1980s. The absolute risk increase of heart disease due to ETS was 2.2%, while the attributable risk percent was 23%. Prolonged secondhand smoke exposure also increases the risk of lung cancer.
Research using more exact measures of second-hand smoke exposure suggests that risks to non-smokers may be even greater than this estimate. A British study reported that exposure to second-hand smoke increases the risk of heart disease among non-smokers by as much as 60%, similar to light smoking. Evidence also shows that inhaled sidestream smoke, the main component of second-hand smoke, is about four times more toxic than mainstream smoke. This fact has been known to the tobacco industry since the 1980s, though it kept its findings secret. Some scientists believe that the risk of passive smoking, in particular the risk of developing coronary heart diseases, may have been substantially underestimated.
A minority of epidemiologists have found it hard to understand how second-hand smoke, which is more diluted than actively inhaled smoke, could have an effect that is such a large fraction of the added risk of coronary heart disease among active smokers. One proposed explanation is that second-hand smoke is not simply a diluted version of "mainstream" smoke, but has a different composition with more toxic substances per gram of total particulate matter. Passive smoking appears to be capable of precipitating the acute manifestations of cardio-vascular diseases (atherothrombosis) and may also have a negative impact on the outcome of patients who suffer acute coronary syndromes.
These meta-analyses show that there is a statistically significant and consistent association between lung cancer risk in spouses of smokers and exposure to second-hand tobacco smoke from the spouse who smokes. The excess risk is of the order of 20% for women and 30% for men and remains after controlling for some potential sources of bias and confounding.
Subsequent meta-analyses have confirmed these findings, and additional studies have found that high overall exposure to passive smoke even among people with non-smoking partners is associated with greater risks than partner smoking and is widespread in non-smokers.
The National Asthma Council of Australia cites studies showing that second-hand smoke is probably the most important indoor pollutant, especially around young children:
Smoking by either parent, particularly by the mother, increases the risk of asthma in children.
The outlook for early childhood asthma is less favourable in smoking households.
Children with asthma who are exposed to smoking in the home generally have more severe disease.
Many adults with asthma identify ETS as a trigger for their symptoms.
Doctor-diagnosed asthma is more common among non-smoking adults exposed to ETS than those not exposed. Among people with asthma, higher ETS exposure is associated with a greater risk of severe attacks.
In France, exposure to second-hand smoke has been estimated to cause between 3,000 and 5,000 premature deaths per year, with the larger figure cited by Prime Minister Dominique de Villepin during his announcement of a nationwide smoke-free law: "That makes more than 13 deaths a day. It is an unacceptable reality in our country in terms of public health."
There is good observational evidence that smoke-free legislation reduces the number of hospital admissions for heart disease. In 2009 two studies in the United States confirmed the effectiveness of public smoking bans in preventing heart attacks. The first study, carried out at the University of California, San Francisco and funded by the National Cancer Institute, found a 15 percent decline in heart-attack hospitalisations in the first year after smoke-free legislation was passed, and 36 percent after three years. The second study, carried out at the University of Kansas School of Medicine, showed similar results. Overall, women, non-smokers, and people under age 60 had the most heart attack risk reduction. Many of those benefiting were hospitality and entertainment industry workers.
The International Agency for Research on Cancer of the World Health Organization concluded in 2004 that there was sufficient evidence that second-hand smoke caused cancer in humans. Most experts conclude that moderate, occasional exposure to second-hand smoke presents a modest but measurable cancer risk to nonsmokers. The overall risk depends on the effective dose received over time. The risk level is higher if non-smokers spend many hours in an environment where cigarette smoke is widespread, such as a business where many employees or patrons are smoking throughout the day, or a residential care facility where residents smoke freely. Those who work in environments where smoke is not regulated are also at higher risk. Workers particularly at risk of exposure include those in installation repair and maintenance, construction and extraction, and transportation.
The US Surgeon General, in his 2006 report, estimated that living or working in a place where smoking is permitted increases the non-smokers' risk of developing heart disease by 25–30% and lung cancer by 20–30%.
Breath CO monitor displaying carbon monoxide concentration of an exhaled breath sample (in ppm) with corresponding percent concentration of carboxyhemoglobin displayed below.
Environmental tobacco smoke can be evaluated either by directly measuring tobacco smoke pollutants found in the air or by using biomarkers, an indirect measure of exposure. Carbon monoxide monitored through breath, nicotine, cotinine, thiocyanates, and proteins are the most specific biological markers of tobacco smoke exposure. Biochemical tests are a much more reliable biomarker of second-hand smoke exposure than surveys. Certain groups of people are reluctant to disclose their smoking status and exposure to tobacco smoke, especially pregnant women and parents of young children. This is due to their smoking being socially unacceptable. Also, it may be difficult for individuals to recall their exposure to tobacco smoke.
A 2007 study in the Addictive Behaviors Journal found a positive correlation between second-hand tobacco smoke exposure and concentrations of nicotine and/or biomarkers of nicotine in the body. Significant biological levels of nicotine from second-hand smoke exposure were equivalent to nicotine levels from active smoking and levels that are associated with behaviour changes due to nicotine consumption.
Cotinine, the metabolite of nicotine, is a biomarker of second-hand smoke exposure. Typically, cotinine is measured in the blood, saliva, and urine. Hair analysis has recently become a new, noninvasive measurement technique. Cotinine accumulates in hair during hair growth, which results in a measure of long-term, cumulative exposure to tobacco smoke. Urinary cotinine levels have been a reliable biomarker of tobacco exposure and have been used as a reference in many epidemiological studies. However, cotinine levels found in the urine only reflect exposure over the preceding 48 hours. Cotinine levels of the skin, such as the hair and nails, reflect tobacco exposure over the previous three months and are a more reliable biomarker.
Carbon monoxide (CO)
Carbon monoxide monitored via breath is also a reliable biomarker of second-hand smoke exposure as well as tobacco use. With high sensitivity and specificity, it not only provides an accurate measure, but the test is also non-invasive, highly reproducible, and low in cost. Breath CO monitoring measures the concentration of CO in an exhalation in parts per million, and this can be directly correlated to the blood CO concentration (carboxyhemoglobin). Breath CO monitors can also be used by emergency services to identify patients who are suspected of having CO poisoning.
Second-hand smoke has been shown to produce more particulate-matter (PM) pollution than an idling low-emission diesel engine. In an experiment conducted by the Italian National Cancer Institute, three cigarettes were left smoldering, one after the other, in a 60 m³ garage with a limited air exchange. The cigarettes produced PM pollution exceeding outdoor limits, as well as PM concentrations up to 10-fold that of the idling engine.
Tobacco smoke exposure has immediate and substantial effects on blood and blood vessels in a way that increases the risk of a heart attack, particularly in people already at risk. Exposure to tobacco smoke for 30 minutes significantly reduces coronary flow velocity reserve in healthy nonsmokers.
Pulmonary emphysema can be induced in rats through acute exposure to sidestream tobacco smoke (30 cigarettes per day) over a period of 45 days. Degranulation of mast cells contributing to lung damage has also been observed.
The term "third-hand smoke" was recently coined to identify the residual tobacco smoke contamination that remains after the cigarette is extinguished and second-hand smoke has cleared from the air. Preliminary research suggests that by-products of third-hand smoke may pose a health risk, though the magnitude of risk, if any, remains unknown. In October 2011, it was reported that Christus St. Frances Cabrini Hospital in Alexandria, Louisiana would seek to eliminate third-hand smoke beginning in July 2012, and that employees whose clothing smelled of smoke would not be allowed to work. This prohibition was enacted because third-hand smoke poses a special danger for the developing brains of infants and small children.
In 2008, there were more than 161,000 deaths attributed to lung cancer in the United States. Of these deaths, an estimated 10% to 15% were caused by factors other than first-hand smoking; equivalent to 16,000 to 24,000 deaths annually. Slightly more than half of the lung cancer deaths caused by factors other than first-hand smoking were found in nonsmokers. Lung cancer in non-smokers may well be considered one of the most common cancer mortalities in the United States. Clinical epidemiology of lung cancer has linked the primary factors closely tied to lung cancer in non-smokers as exposure to second-hand tobacco smoke, carcinogens including radon, and other indoor air pollutants.
Opinion of public health authorities
There is widespread scientific consensus that exposure to second-hand smoke is harmful. The link between passive smoking and health risks is accepted by every major medical and scientific organisation, including:
Recent major surveys conducted by the U.S. National Cancer Institute and Centers for Disease Control have found widespread public awareness that second-hand smoke is harmful. In both 1992 and 2000 surveys, more than 80% of respondents agreed with the statement that second-hand smoke was harmful. A 2001 study found that 95% of adults agreed that second-hand smoke was harmful to children, and 96% considered tobacco-industry claims that second-hand smoke was not harmful to be untruthful.
A 2007 Gallup poll found that 56% of respondents felt that second-hand smoke was "very harmful", a number that has held relatively steady since 1997. Another 29% believe that second-hand smoke is "somewhat harmful"; 10% answered "not too harmful", while 5% said "not at all harmful".
Controversy over harm
As part of its attempt to prevent or delay tighter regulation of smoking, the tobacco industry funded a number of scientific studies and, where the results cast doubt on the risks associated with second-hand smoke, sought wide publicity for those results. The industry also funded libertarian and conservative think tanks, such as the Cato Institute in the United States and the Institute of Public Affairs in Australia which criticised both scientific research on passive smoking and policy proposals to restrict smoking.New Scientist and the European Journal of Public Health have identified these industry-wide coordinated activities as one of the earliest expressions of corporate denialism. Further, they state that the disinformation spread by the tobacco industry has created a tobacco denialism movement, sharing many characteristics of other forms of denialism, such as HIV-AIDS denialism.
Recent research not funded by the tobacco industry suggests little or no harm, except in those who live with a smoker for more than 30 years.
Industry-funded studies and critiques
Enstrom and Kabat
A 2003 study by James Enstrom and Geoffrey Kabat, published in the British Medical Journal, argued that the harms of passive smoking had been overstated. Their analysis reported no statistically significant relationship between passive smoking and lung cancer, though the accompanying editorial noted that "they may overemphasise the negative nature of their findings." This paper was widely promoted by the tobacco industry as evidence that the harms of passive smoking were unproven. The American Cancer Society (ACS), whose database Enstrom and Kabat used to compile their data, criticized the paper as "neither reliable nor independent", stating that scientists at the ACS had repeatedly pointed out serious flaws in Enstrom and Kabat's methodology prior to publication. Notably, the study had failed to identify a comparison group of "unexposed" persons.
Enstrom's ties to the tobacco industry also drew scrutiny; in a 1997 letter to Philip Morris, Enstrom requested a "substantial research commitment... in order for me to effectively compete against the large mountain of epidemiologic data and opinions that already exist regarding the health effects of ETS and active smoking." In a US racketeering lawsuit against tobacco companies, the Enstrom and Kabat paper was cited by the US District Court as "a prime example of how nine tobacco companies engaged in criminal racketeering and fraud to hide the dangers of tobacco smoke." The Court found that the study had been funded and managed by the Center for Indoor Air Research, a tobacco industry front group tasked with "offsetting" damaging studies on passive smoking, as well as by Phillip Morris who stated that Enstrom's work was "clearly litigation-oriented." Enstrom has defended the accuracy of his study against what he terms "illegitimate criticism by those who have attempted to suppress and discredit it."
Gio Batta Gori, a tobacco industry spokesman and consultant and an expert on risk utility and scientific research, wrote in the libertarianCato Institute's journal Regulation that "...of the 75 published studies of ETS and lung cancer, some 70 percent did not report statistically significant differences of risk and are moot. Roughly 17 percent claim an increased risk and 13 percent imply a reduction of risk."
Another component of criticism cited by Milloy focused on relative risk and epidemiological practices in studies of passive smoking. Milloy, who has a master's degree from the Johns Hopkins School of Hygiene and Public Health, argued that studies yielding relative risks of less than 2 were meaningless junk science. This approach to epidemiological analysis was criticized in the American Journal of Public Health:
A major component of the industry attack was the mounting of a campaign to establish a "bar" for "sound science" that could not be fully met by most individual investigations, leaving studies that did not meet the criteria to be dismissed as "junk science."
The tobacco industry and affiliated scientists also put forward a set of "Good Epidemiology Practices" which would have the practical effect of obscuring the link between secondhand smoke and lung cancer; the privately stated goal of these standards was to "impede adverse legislation". However, this effort was largely abandoned when it became clear that no independent epidemiological organization would agree to the standards proposed by Philip Morris et al.
World Health Organization controversy
A 1998 report by the International Agency for Research on Cancer (IARC) on environmental tobacco smoke (ETS) found "weak evidence of a dose-response relationship between risk of lung cancer and exposure to spousal and workplace ETS."
In March 1998, before the study was published, reports appeared in the media alleging that the IARC and the World Health Organization (WHO) were suppressing information. The reports, appearing in the British Sunday Telegraph and The Economist, among other sources, alleged that the WHO withheld from publication of its own report that supposedly failed to prove an association between passive smoking and a number of other diseases (lung cancer in particular).
In response, the WHO issued a press release stating that the results of the study had been "completely misrepresented" in the popular press and were in fact very much in line with similar studies demonstrating the harms of passive smoking. The study was published in the Journal of the National Cancer Institute in October of the same year, and concluded the authors found "no association between childhood exposure to ETS and lung cancer risk" but "did find weak evidence of a dose–response relationship between risk of lung cancer and exposure to spousal and workplace ETS." An accompanying editorial summarized:
When all the evidence, including the important new data reported in this issue of the Journal, is assessed, the inescapable scientific conclusion is that ETS is a low-level lung carcinogen.
With the release of formerly classified tobacco industry documents through the Tobacco Master Settlement Agreement, it was found[by whom?] that the controversy over the WHO's alleged suppression of data had been engineered by Philip Morris, British American Tobacco, and other tobacco companies in an effort to discredit scientific findings which would harm their business interests. A WHO inquiry, conducted after the release of the tobacco-industry documents, found that this controversy was generated by the tobacco industry as part of its larger campaign to cut the WHO's budget, distort the results of scientific studies on passive smoking, and discredit the WHO as an institution. This campaign was carried out using a network of ostensibly independent front organizations and international and scientific experts with hidden financial ties to the industry.
Philip Morris, R.J. Reynolds Tobacco Company, and groups representing growers, distributors and marketers of tobacco took legal action, claiming that the EPA had manipulated this study and ignored accepted scientific and statistical practices.
The United States District Court for the Middle District of North Carolina ruled in favor of the tobacco industry in 1998, finding that the EPA had failed to follow proper scientific and epidemiologic practices and had "cherry picked" evidence to support conclusions which they had committed to in advance. The court stated in part, "EPA publicly committed to a conclusion before research had begun…adjusted established procedure and scientific norms to validate the Agency's public conclusion... In conducting the ETS Risk Assessment, disregarded information and made findings on selective information; did not disseminate significant epidemiologic information; deviated from its Risk Assessment Guidelines; failed to disclose important findings and reasoning…"
In 1998, the U.S. Department of Health and Human Services, through the publication by its National Toxicology Program of the 9th Report on Carcinogens, listed environmental tobacco smoke among the known carcinogens, observing of the EPA assessment that "The individual studies were carefully summarized and evaluated."
Tobacco-industry funding of research
The tobacco industry's role in funding scientific research on second-hand smoke has been controversial. A review of published studies found that tobacco-industry affiliation was strongly correlated with findings exonerating second-hand smoke; researchers affiliated with the tobacco industry were 88 times more likely than independent researchers to conclude that second-hand smoke was not harmful. In a specific example which came to light with the release of tobacco-industry documents, Philip Morris executives successfully encouraged an author to revise his industry-funded review article to downplay the role of second-hand smoke in sudden infant death syndrome. The 2006 U.S. Surgeon General's report criticized the tobacco industry's role in the scientific debate:
The industry has funded or carried out research that has been judged to be biased, supported scientists to generate letters to editors that criticized research publications, attempted to undermine the findings of key studies, assisted in establishing a scientific society with a journal, and attempted to sustain controversy even as the scientific community reached consensus.
This strategy was outlined at an international meeting of tobacco companies in 1988, at which Philip Morris proposed to set up a team of scientists, organized by company lawyers, to "carry out work on ETS to keep the controversy alive." All scientific research was subject to oversight and "filtering" by tobacco-industry lawyers:
Philip Morris then expect the group of scientists to operate within the confines of decisions taken by PM scientists to determine the general direction of research, which apparently would then be 'filtered' by lawyers to eliminate areas of sensitivity.
Philip Morris reported that it was putting "...vast amounts of funding into these projects... in attempting to coordinate and pay so many scientists on an international basis to keep the ETS controversy alive."
Tobacco industry response
Measures to tackle second-hand smoke pose a serious economic threat to the tobacco industry, having broadened the definition of smoking beyond a personal habit to something with a social impact. In a confidential 1978 report, the tobacco industry described increasing public concerns about second-hand smoke as "the most dangerous development to the viability of the tobacco industry that has yet occurred." In United States of America v. Philip Morris et al., the District Court for the District of Columbia found that the tobacco industry "... recognized from the mid-1970s forward that the health effects of passive smoking posed a profound threat to industry viability and cigarette profits," and that the industry responded with "efforts to undermine and discredit the scientific consensus that ETS causes disease."
Accordingly, the tobacco industry have developed several strategies to minimise the impact on their business:
The industry has sought to position the second-hand smoke debate as essentially concerned with civil liberties and smokers' rights rather than with health, by funding groups such as FOREST.
Funding bias in research; in all reviews of the effects of second-hand smoke on health published between 1980 and 1995, the only factor associated with concluding that second-hand smoke is not harmful was whether an author was affiliated with the tobacco industry. However, not all studies that failed to find evidence of harm were by industry-affiliated authors.
Delaying and discrediting legitimate research (see for an example of how the industry attempted to discredit Hirayama's landmark study, and for an example of how it attempted to delay and discredit a major Australian report on passive smoking)
Promoting "good epidemiology" and attacking so-called junk science (a term popularised by industry lobbyist Steven Milloy): attacking the methodology behind research showing health risks as flawed and attempting to promote sound science. Ong & Glantz (2001) cite an internal Phillip Morris memo giving evidence of this as company policy.
Creation of outlets for favourable research. In 1989, the tobacco industry established the International Society of the Built Environment, which published the peer-reviewed journal Indoor and Built Environment. This journal did not require conflict-of-interest disclosures from its authors. With documents made available through the Master Settlement, it was found that the executive board of the society and the editorial board of the journal were dominated by paid tobacco-industry consultants. The journal published a large amount of material on passive smoking, much of which was "industry-positive".
Citing the tobacco industry's production of biased research and efforts to undermine scientific findings, the 2006 U.S. Surgeon General's report concluded that the industry had "attempted to sustain controversy even as the scientific community reached consensus... industry documents indicate that the tobacco industry has engaged in widespread activities... that have gone beyond the bounds of accepted scientific practice." The U.S. District Court, in U.S.A. v. Philip Morris et al., found that "...despite their internal acknowledgment of the hazards of secondhand smoke, Defendants have fraudulently denied that ETS causes disease."
Position of major tobacco companies
The positions of major tobacco companies on the issue of second-hand smoke is somewhat varied. In general, tobacco companies have continued to focus on questioning the methodology of studies showing that second-hand smoke is harmful. Some (such as British American Tobacco and Philip Morris) acknowledge the medical consensus that second-hand smoke carries health risks, while others continue to assert that the evidence is inconclusive. Imperial Tobacco describes second-hand smoke as "annoying" and "unpleasant", but denies any associated health risks. Several tobacco companies advocate the creation of smoke-free areas within public buildings as an alternative to comprehensive smoke-free laws.
conspired to minimize, distort and confuse the public about the health hazards of smoking;
publicly denied, while internally acknowledging, that second-hand tobacco smoke is harmful to nonsmokers, and
destroyed documents relevant to litigation.
The ruling found that tobacco companies undertook joint efforts to undermine and discredit the scientific consensus that second-hand smoke causes disease, notably by controlling research findings via paid consultants. The ruling also concluded that tobacco companies continue today to fraudulently deny the health effects of ETS exposure.
On May 22, 2009, a three-judge panel of the U.S. Court of Appeals for the District of Columbia Circuit unanimously upheld the lower court's 2006 ruling.
As a consequence of the health risks associated with second-hand smoke, smoke-free regulations in indoor public places, including restaurants, cafés, and nightclubs have been introduced in a number of jurisdictions, at national or local level, as well as some outdoor open areas. 1Ireland was the first country in the world to institute a comprehensive national smoke-free law on smoking in all indoor workplaces on 29 March 2004. Since then, many others have followed suit. The countries which have ratified the WHO Framework Convention on Tobacco Control (FCTC) have a legal obligation to implement effective legislation "for protection from exposure to tobacco smoke in indoor workplaces, public transport, indoor public places and, as appropriate, other public places." (Article 8 of the FCTC) The parties to the FCTC have further adopted Guidelines on the Protection from Exposure to Second-hand Smoke which state that "effective measures to provide protection from exposure to tobacco smoke ... require the total elimination of smoking and tobacco smoke in a particular space or environment in order to create a 100% smoke-free environment."
Opinion polls have shown considerable support for smoke-free laws. In June 2007, a survey of 15 countries found 80% approval for smoke-free laws. A survey in France, reputedly a nation of smokers, showed 70% support.
In the first 18 months after the town of Pueblo, Colorado enacted a smoke-free law in 2003, hospital admissions for heart attacks dropped 27%. Admissions in neighbouring towns without smoke-free laws showed no change, and the decline in heart attacks in Pueblo was attributed to the resulting reduction in second-hand smoke exposure. A 2004 smoking ban instituted in Massachusetts workplaces decreased workers' secondhand smoke exposure from 8% of workers in 2003 to 5.4% of workers in 2010.
In April 2010 the Canadian Medical Association Journal published a study evaluating the effects of a 10-year, three-stage smoke-free regulatory programme in Toronto. The study found that during the implementation of a restaurant smoke-free ordinance, hospital admissions for cardiovascular conditions declined by 39%, and admissions for respiratory conditions declined by 33%. No significant reductions in hospital admissions occurred in other cities which did not have smoke-free ordinances. The authors concluded that the study justified further efforts to reduce public exposure to tobacco smoke. In May 2006, Ontario instituted a comprehensive province-wide smoke-free law which extended the restrictions to all cities and municipalities in Ontario. However, not all researchers agree that this was a causal relationship, and a 2009 study of many smoke-free ordinances in the United States disagreed with these conclusions.
In 2001, a systematic review for the Guide to Community Preventative Services acknowledged strong evidence of the effectiveness of smoke-free policies and restrictions in reducing expose to second-hand smoke. A follow up to this review, identified the evidence on which the effectiveness of smoking bans reduced the prevalence of tobacco use. Articles published until 2005, were examined to further support this evidence. The examined studies provided sufficient evidence that smoke-free policies reduce tobacco use among workers when implemented in worksites or by communities.
While a number of studies funded by the tobacco industry have claimed a negative economic impact from smoke-free laws, no independently funded research has shown any such impact. A 2003 review reported that independently funded, methodologically sound research consistently found either no economic impact or a positive impact from smoke-free laws.
Air nicotine levels were measured in Guatemalan bars and restaurants before and after an implemented smoke-free law in 2009. Nicotine concentrations significantly decreased in both the bars and restaurants measured. Also, the employees support for a smoke-free workplace substantially increased in the post-implementation survey compared to pre-implementation survey. The result of this smoke-free law provides a considerably more healthy work environment for the staff.
Recent surveys taken by the Society for Research on Nicotine and Tobacco demonstrates supportive attitudes of the public, towards smoke-free policies in outdoor areas. A vast majority of the public supports restricting smoking in various outdoor settings. The respondents reasons for supporting the polices were for varying reasons such as, litter control, establishing positive smoke-free role models for youth, reducing youth opportunities to smoke, and avoiding exposure to secondhand smoke.
Alternatives to smoke-free laws have also been proposed as a means of harm reduction, particularly in bars and restaurants. For example, critics of smoke-free laws cite studies suggesting ventilation as a means of reducing tobacco smoke pollutants and improving air quality. Ventilation has also been heavily promoted by the tobacco industry as an alternative to outright bans, via a network of ostensibly independent experts with often undisclosed ties to the industry. However, not all critics have connections to the industry.
Multiple studies have been conducted to determine the carcinogenicity of environmental tobacco smoke to animals. These studies typically fall under the categories of simulated environmental tobacco smoke, administering condensates of sidestream smoke, or observational studies of cancer among pets.
To simulate environmental tobacco smoke, scientists expose animals to sidestream smoke, that which emanates from the cigarette's burning cone and through its paper, or a combination of mainstream and sidestream smoke. The IARC monographs conclude that mice with prolonged exposure to simulated environmental tobacco smoke, that is 6hrs a day, 5 days a week, for five months with a subsequent 4 month interval before dissection, will have significantly higher incidence and multiplicity of lung tumors than with control groups.
The IARC monographs concluded that sidestream smoke condensates had a significantly higher carcinogenic effect on mice than did mainstream smoke condensates.
Second-hand smoke is popularly recognised as a risk factor for cancer in pets. A study conducted by the Tufts University School of Veterinary Medicine and the University of Massachusetts Amherst linked the occurrence of feline oral cancer to exposure to environmental tobacco smoke through an overexpression of the p53 gene. Another study conducted at the same universities concluded that cats living with a smoker were more likely to get feline lymphoma; the risk increased with the duration of exposure to secondhand smoke and the number of smokers in the household. A study by Colorado State University researchers, looking at cases of canine lung cancer, was generally inconclusive, though the authors reported a weak relation for lung cancer in dogs exposed to environmental tobacco smoke. The number of smokers within the home, the number of packs smoked in the home per day, and the amount of time that the dog spent within the home had no effect on the dog's risk for lung cancer.
^ abcDiethelm P, McKee M (February 2006). "Lifting the smokescreen: Tobacco industry strategy to defeat smoke free policies and legislation"(PDF). European Respiratory Society and Institut National du Cancer. Retrieved 2009-01-17. The industry quickly realised that, if it wanted to continue to prosper, it became vital that research did not demonstrate that tobacco smoke was a dangerous community air pollutant. This requirement has been the central pillar of its passive smoking policy from the early 1970s to the present day
^Alberg, Anthony J.; Brock, Malcolm V.; Ford, Jean G.; Samet, Jonathan M.; Spivack, Simon D. (1 May 2013). "Epidemiology of Lung Cancer". CHEST Journal143 (5_suppl): e1S. doi:10.1378/chest.12-2345.
^Bhatnagar, A; Whitsel, LP; Ribisl, KM; Bullen, C; Chaloupka, F; Piano, MR; Robertson, RM; McAuley, T; Goff, D; Benowitz, N; American Heart Association Advocacy Coordinating Committee, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes, Research (14 October 2014). "Electronic cigarettes: a policy statement from the American Heart Association.". Circulation130 (16): 1418–36. PMID25156991.
^Dinas, PC; Koutedakis, Y; Flouris, AD (20 February 2013). "Effects of active and passive tobacco cigarette smoking on heart rate variability.". International journal of cardiology163 (2): 109–15. doi:10.1016/j.ijcard.2011.10.140. PMID22100604.
^Zou N, Hong J, Dai QY; Hong; Dai (February 2009). "Passive cigarette smoking induces inflammatory injury in human arterial walls". Chin. Med. J.122 (4): 444–8. PMID19302752.
^Bentayeb, M; Simoni, M; Norback, D; Baldacci, S; Maio, S; Viegi, G; Annesi-Maesano, I (2013). "Indoor air pollution and respiratory health in the elderly.". Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering48 (14): 1783–9. PMID24007433.
^Chen, R; Hu, Z; Orton, S; Chen, RL; Wei, L (December 2013). "Association of passive smoking with cognitive impairment in nonsmoking older adults: a systematic literature review and a new study of Chinese cohort.". Journal of geriatric psychiatry and neurology26 (4): 199–208. doi:10.1177/0891988713496165. PMID23877565.
^Been, Jasper; Nurmatov, U. B.; Cox, B; Nawrot, T. S.; Van Schayck, C. P.; Sheikh, A (Mar 28, 2014). "Effect of smoke-free legislation on perinatal and child health: a systematic review and meta-analysis". Lancet383 (9928): 1549–60. doi:10.1016/S0140-6736(14)60082-9. PMID24680633.
^Geerts CC, Bots ML, van der Ent CK, Grobbee DE, Uiterwaal CS; Bots; Van Der Ent; Grobbee; Uiterwaal (January 2012). "Parental smoking and vascular damage in their 5-year-old children". Pediatrics129 (1): 45–54. doi:10.1542/peds.2011-0249. PMID22201150.
^Salmasi G, Grady R, Jones J, McDonald SD; Grady; Jones; McDonald; Knowledge Synthesis (2010). "Environmental tobacco smoke exposure and perinatal outcomes: a systematic review and meta-analyses". Acta Obstet Gynecol Scand89 (4): 423–41. doi:10.3109/00016340903505748. PMID20085532.
^Janson C (2004). "The effect of passive smoking on respiratory health in children and adults". Int J Tuberc Lung Dis8 (5): 510–6. PMID15137524.
^Wei, X; E, M; Yu, S (January 2015). "A meta-analysis of passive smoking and risk of developing Type 2 Diabetes Mellitus.". Diabetes research and clinical practice107 (1): 9–14. doi:10.1016/j.diabres.2014.09.019. PMID25488377.
^ abChatzimichael A, Tsalkidis A, Cassimos D et al. (2007). "The role of breastfeeding and passive smoking on the development of severe bronchiolitis in infants". Minerva Pediatr.59 (3): 199–206. PMID17519864.
^den Boon S, Verver S, Marais BJ et al. (2007). "Association between passive smoking and infection with Mycobacterium tuberculosis in children". Pediatrics119 (4): 734–9. doi:10.1542/peds.2006-1796. PMID17403844.
^Feleszko, W; Ruszczyński, M; Jaworska, J; Strzelak, A; Zalewski, BM; Kulus, M (November 2014). "Environmental tobacco smoke exposure and risk of allergic sensitisation in children: a systematic review and meta-analysis.". Archives of disease in childhood99 (11): 985–92. doi:10.1136/archdischild-2013-305444. PMID24958794.
^Mahid SS, Minor KS, Stromberg AJ, Galandiuk S; Minor; Stromberg; Galandiuk (2007). "Active and passive smoking in childhood is related to the development of inflammatory bowel disease". Inflamm. Bowel Dis.13 (4): 431–8. doi:10.1002/ibd.20070. PMID17206676.
^Richards GA, Terblanche AP, Theron AJ et al. (1996). "Health effects of passive smoking in adolescent children". S. Afr. Med. J.86 (2): 143–7. PMID8619139.
^Diethelm PA, Rielle JC, McKee M; Rielle; McKee (2005). "The whole truth and nothing but the truth? The research that Philip Morris did not want you to see". Lancet366 (9479): 86–92. doi:10.1016/S0140-6736(05)66474-4. PMID15993237.
^Schick SF, Glantz S; Glantz (2007). "Concentrations of the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in sidestream cigarette smoke increase after release into indoor air: results from unpublished tobacco industry research". Cancer Epidemiol. Biomarkers Prev.16 (8): 1547–53. doi:10.1158/1055-9965.EPI-07-0210. PMID17684127.
^Raupach T, Schäfer K, Konstantinides S and Andreas S (2006). "Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm". European Heart Journal27 (4): 386–392. doi:10.1093/eurheartj/ehi601. PMID16230308.
^ abcBoffetta P, Agudo A, Ahrens W et al. (1998). "Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe". J. Natl. Cancer Inst.90 (19): 1440–50. doi:10.1093/jnci/90.19.1440. PMID9776409.
^Klesges RC, Debon M, Ray JW; Debon; Ray (October 1995). "Are self-reports of smoking rate biased? Evidence from the Second National Health and Nutrition Examination Survey". J Clin Epidemiol48 (10): 1225–33. doi:10.1016/0895-4356(95)00020-5. PMID7561984.
^Irving JM, Clark EC, Crombie IK, Smith WC; Clark; Crombie; Smith (January 1988). "Evaluation of a portable measure of expired-air carbon monoxide". Prev Med17 (1): 109–15. doi:10.1016/0091-7435(88)90076-X. PMID3362796.
^Tong EK, England L, Glantz SA; England; Glantz (2005). "Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry". Pediatrics115 (3): e356–66. doi:10.1542/peds.2004-1922. PMID15741361.
^Garne D, Watson M, Chapman S, Byrne F; Watson; Chapman; Byrne (2005). "Environmental tobacco smoke research published in the journal Indoor and Built Environment and associations with the tobacco industry". Lancet365 (9461): 804–9. doi:10.1016/S0140-6736(05)17990-2. PMID15733724.
^The most current positions of major tobacco companies on the issue of passive smoking can be found on their websites. As of 13 January 2009, the following websites contain tobacco-industry positions on the topic:
^Barnoya J, Arvizu M, Jones MR, Hernandez JC, Breysse PN, Navas-Acien A; Arvizu; Jones; Hernandez; Breysse; Navas-Acien (November 2010). "Secondhand smoke exposure in bars and restaurants in Guatemala City: before and after smoking ban evaluation". Cancer Causes Control22 (1): 151–6. doi:10.1007/s10552-010-9673-8. PMID21046446.
^Snyder LA, Bertone ER, Jakowski RM, Dooner MS, Jennings-Ritchie J, Moore AS.; Bertone; Jakowski; Dooner; Jennings-Ritchie; Moore (2004). "p53 expression and environmental tobacco smoke exposure in feline oral squamous cell carcinoma". Vet Pathol41 (3): 209–14. doi:10.1354/vp.41-3-209. PMID15133168.
^Bertone ER, Snyder LA, Moore AS.; Snyder; Moore (2002). "Environmental Tobacco Smoke and Risk of Malignant Lymphoma in Pet Cats". American Journal of Epidemiology156 (3): 268–273. doi:10.1093/aje/kwf044. PMID12142262.
^Reif JS, Dunn K, Ogilvie GK, Harris CK.; Dunn; Ogilvie; Harris (1992). "Passive smoking and canine lung cancer risk". Am J Epidemiol.135 (3): 234–9. PMID1546698.